Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1210)
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Leonard Keith R — Director
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific & Med Officer
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$25.65
Total Value
$256.52K
Shares Held After
49,744
% of Holdings
16.7%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$29.72
Total Value
$267.49K
Shares Held After
89,389
% of Holdings
9.1%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
7,132
Price
$2.60
Total Value
$18.54K
Shares Held After
203,040
% of Holdings
3.4%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$29.29
Total Value
$59.58K
Shares Held After
237,660
% of Holdings
0.8%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,305
Price
$35.30
Total Value
$363.77K
Shares Held After
16,080
% of Holdings
39.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
5,714
Price
$45.92
Total Value
$262.39K
Shares Held After
61,324
% of Holdings
8.5%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
22,223
Price
$44.88
Total Value
$997.37K
Shares Held After
67,038
% of Holdings
24.9%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
12,063
Price
$44.20
Total Value
$533.18K
Shares Held After
89,261
% of Holdings
11.9%
Vanda Pharmaceuticals Inc. (VNDA)
Polymeropoulos Mihael Hristos — Director
Shares
156,235
Price
$8.17
Total Value
$1.28M
Shares Held After
2,704,496
% of Holdings
5.5%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$35.36
Total Value
$530.40K
Shares Held After
1,262
% of Holdings
92.2%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
6,421
Price
$34.75
Total Value
$223.13K
Shares Held After
1,262
% of Holdings
83.6%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
100
Price
$10.83
Total Value
$1.08K
Shares Held After
21,906
% of Holdings
0.5%
Vanda Pharmaceuticals Inc. (VNDA)
Birznieks Gunther — SVP, Business Development
Shares
42,431
Price
$8.27
Total Value
$350.73K
Shares Held After
494,197
% of Holdings
7.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Smethurst Dominic — Chief Medical Officer
Shares
6,097
Price
$8.30
Total Value
$50.60K
Shares Held After
89,790
% of Holdings
6.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
583
Price
$47.01
Total Value
$27.41K
Shares Held After
45,761
% of Holdings
1.3%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,292
Price
$46.67
Total Value
$60.30K
Shares Held After
46,344
% of Holdings
2.7%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
10,429
Price
$47.01
Total Value
$490.31K
Shares Held After
98,748
% of Holdings
9.6%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
22,487
Price
$46.67
Total Value
$1.05M
Shares Held After
109,177
% of Holdings
17.1%
Whitehawk Therapeutics, Inc. (WHWK)
Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Shares
2,594
Price
$3.31
Total Value
$8.59K
Shares Held After
28,100
% of Holdings
8.5%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
1,834
Price
$3.31
Total Value
$6.07K
Shares Held After
206,019
% of Holdings
0.9%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
5,100
Price
$3.31
Total Value
$16.88K
Shares Held After
44,579
% of Holdings
10.3%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
81,864
Price
$2.12
Total Value
$173.82K
Shares Held After
2,338,176
% of Holdings
3.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
3,119
Price
$22.54
Total Value
$70.30K
Shares Held After
86,669
% of Holdings
3.5%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
5,290
Price
$22.80
Total Value
$120.61K
Shares Held After
89,788
% of Holdings
5.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
1,163
Price
$28.96
Total Value
$33.68K
Shares Held After
44,086
% of Holdings
2.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
41,329
% of Holdings
2.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
38,516
% of Holdings
4.2%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
34,531
% of Holdings
3.3%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
827
Price
$30.58
Total Value
$25.29K
Shares Held After
188,954
% of Holdings
0.4%
CYTOKINETICS INC (CYTK)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$61.21
Total Value
$306.05K
Shares Held After
17,933
% of Holdings
21.8%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
886
Price
$61.62
Total Value
$54.60K
Shares Held After
50,440
% of Holdings
1.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Dier Mardi — EVP and CFO
Shares
1,183
Price
$427.21
Total Value
$505.39K
Shares Held After
9,257
% of Holdings
11.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
443,707
Price
$33.25
Total Value
$14.75M
Shares Held After
174,144
% of Holdings
71.8%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
536
Price
$17.50
Total Value
$9.38K
Shares Held After
22,693
% of Holdings
2.3%
Alkermes plc. (ALKS)
Parisi Samuel Joseph — VP, Finance (Interim PAO)
Shares
6,890
Price
$29.29
Total Value
$201.81K
Shares Held After
7,717
% of Holdings
47.2%
Alkermes plc. (ALKS)
Nichols Christian Todd — SVP, Chief Commercial Officer
Shares
6,000
Price
$30.00
Total Value
$180.00K
Shares Held After
109,769
% of Holdings
5.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
10,000
Price
$15.72
Total Value
$157.20K
Shares Held After
1,169,524
% of Holdings
0.8%
AMICUS THERAPEUTICS, INC. (FOLD)
Campbell Bradley L — Director
Shares
22,500
Price
$14.35
Total Value
$322.84K
Shares Held After
998,680
% of Holdings
2.2%
Showing 951–1000 of 1210 transactions (page 20 of 25)